Published in Hypertension on October 10, 1985
Hyponatremia. N Engl J Med (2000) 11.31
Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem (1992) 8.84
Kidney transplantation under FK 506. JAMA (1990) 7.45
Trapped by an incidental finding. N Engl J Med (1992) 6.50
Hypernatremia. N Engl J Med (2000) 5.10
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Management of life-threatening acid-base disorders. First of two parts. N Engl J Med (1998) 4.06
Clinical problem-solving. Diverted by the chief complaint. N Engl J Med (1995) 3.95
Clinical problem-solving. Invasive interventions. N Engl J Med (1994) 3.94
Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med (1983) 3.63
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76
Management of life-threatening acid-base disorders. Second of two parts. N Engl J Med (1998) 2.69
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
Characterization of influenza virus RNA complete transcripts. Virology (1982) 2.31
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
Serum creatinine and renal function. Annu Rev Med (1988) 2.28
Cognitive errors in diagnosis: instantiation, classification, and consequences. Am J Med (1989) 2.10
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
Assessing acid-base status in circulatory failure. Differences between arterial and central venous blood. N Engl J Med (1989) 2.04
Clinical problem-solving. Some familiar trade-offs. N Engl J Med (1994) 2.03
Treating before knowing. N Engl J Med (1992) 2.02
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet (1990) 1.94
Influenza virus RNA segment 7 has the coding capacity for two polypeptides. Virology (1980) 1.80
Platinum nephrotoxicity. Am J Med (1978) 1.73
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc (1993) 1.72
Nucleotide sequences at the terminal of La Crosse virus RNAs. Nucleic Acids Res (1980) 1.61
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology (2005) 1.56
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A (1999) 1.54
Interpreting hoofbeats: can Bayes help clear the haze? N Engl J Med (1992) 1.51
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome. Br J Obstet Gynaecol (1994) 1.43
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Clinical problem-solving. A rewarding pursuit of certainty. N Engl J Med (1993) 1.40
Diagnosis by fiat. Hosp Pract (Off Ed) (1990) 1.39
Diagnosis and the structure of memory. 4. The power of reminding. Hosp Pract (Off Ed) (1991) 1.39
Weak reasoning: diagnosis by drug reaction. N Engl J Med (1993) 1.39
Admission serum magnesium level does not predict the hospital outcome of patients with acute myocardial infarction. Arch Intern Med (1996) 1.38
The case presentation: I. Principles. Hosp Pract (Off Ed) (1988) 1.38
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med (1981) 1.32
BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis (1995) 1.28
Lactic acidosis. Kidney Int (1986) 1.17
Drug-induced hyperkalemia. Medicine (Baltimore) (1985) 1.16
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant (1994) 1.15
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation (1999) 1.14
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc (1995) 1.13
FK506 in pediatric kidney transplantation--primary and rescue experience. Pediatr Nephrol (1995) 1.11
Tacrolimus in renal transplantation. Transplant Proc (1996) 1.10
Diagnosis of deep venous thrombosis in the outpatient by venography. Surg Gynecol Obstet (1980) 1.09
An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. J Clin Pharmacol (1993) 1.09
Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension. Arch Intern Med (1984) 1.09
Auscultation of cervical and ocular bruits in extracranial carotid occlusive disease: a clinical and angiographic study. Stroke (1983) 1.07
Postemetic dissecting intramural hematoma of the esophagus. Radiology (1970) 1.05
The spectrum of ciclosporin nephrotoxicity. Am J Nephrol (1990) 1.05
Cisplatin nephrotoxicity. Miner Electrolyte Metab (1994) 1.05
Risky business. N Engl J Med (1992) 1.04
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol (1993) 1.02
Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation (1999) 1.00
Aiding fluid prescription for the dysnatremias. Intensive Care Med (1997) 0.99
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. Transplant Proc (1997) 0.98
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant (2008) 0.98
Predominant tubulointerstitial lupus nephritis. Am J Kidney Dis (1996) 0.98
Increased anion gap in metabolic alkalosis: the role of plasma-protein equivalency. N Engl J Med (1979) 0.98
Diagnostic evaluation of hirsutism in women by selective bilateral adrenal and ovarian venous catheterization. Fertil Steril (1978) 0.97
Nonsurgical treatment of severe hypertension due to renal-artery intimal fibroplasia by percutaneous transluminal angioplasty. N Engl J Med (1979) 0.97
Structure and synthesis of influenza virus complementary RNAs. Philos Trans R Soc Lond B Biol Sci (1980) 0.97
Precordial ST-segment mapping. 2. Effects of oxygen inhalation on ischemic injury in patients with acute myocardial infarction. Circulation (1976) 0.96
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation (1999) 0.96
Interferon-alpha-induced acute renal allograft rejection. Transplantation (1995) 0.95
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation (1997) 0.95
Severe lactic acidosis as a presenting feature of pheochromocytoma. Am J Kidney Dis (1987) 0.94
Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension (1989) 0.94
Endothelin-1 stimulates the Na+/H+ and Na+/HCO3- transporters in rabbit renal cortex. Kidney Int (1992) 0.94
Percutaneous transluminal renal angioplasty. A potentially effective treatment for preservation of renal function. Arch Intern Med (1982) 0.93
Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant (2007) 0.92
Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis (1991) 0.92
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc (1998) 0.91
Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist? Transplantation (2000) 0.91
Toluidine blue in the corroboration of rape in the adult victim. Am J Emerg Med (1987) 0.91
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. Clin Transplant (1997) 0.90
PORCN gene mutations and the protean nature of focal dermal hypoplasia. Br J Dermatol (2009) 0.90
Infrarenal aortic occlusion: a reassessment of surgical indications. Am J Surg (1983) 0.90
Toluidine blue in the detection of perineal lacerations in pediatric and adolescent sexual abuse victims. Pediatrics (1986) 0.90
Methods for the detection of non-random base substitution in virus genes: models of synonymous nucleotide substitution in picornavirus genes. Virus Genes (1998) 0.89
Clinical problem-solving. A masked marauder. N Engl J Med (1994) 0.89
Hypochloremia as a consequence of anion gap metabolic acidosis. J Lab Clin Med (1984) 0.89
Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transplant Proc (2005) 0.88
Clinical problem solving at grand rounds. Hosp Pract (Off Ed) (1990) 0.88
Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome. Chest (2000) 0.88
Formation of myocardial zonal lesions. Am J Pathol (1975) 0.87